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Setting: A rural community in Chingleput district in Tamil Nadu state in south India.
Objective: To determine the value of dual testing with PPD-S and PPD-B for
identifying subjects with a tuberculous infection.
Design: About 240,000 subjects in rural south India, all of whom were tested
initially with PPD-S and PPD-B, were followed up for 15 years, mainly by total
population survey once in every 212 years. The incidence of culture-positive
tuberculosis was estimated using life-table technique.
Results: Among 17,530 subjects with an intermediate reaction (8–11mm) to PPD-S
at intake, 285 with an induration to PPD-S exceeding the induration to PPD-B by at
least 2mm, had a significantly higher incidence of culture-positive tuberculosis than
the remaining (154 and 93 per 100,000), and similarly 481 who had an induration of
o10mm to PPD-B compared to those withX10mm (131 and 93 per 100,000). These
subjects may be regarded as having a tuberculous infection.
Infection with non-tuberculous mycobacteria conferred protection of about 30%
against the development of tuberculosis over a 15-year period.
Conclusion: In subjects with an intermediate reaction (8–11mm) to PPD-S, dual
testing with PPD-B enabled identification of those with a tuberculous infection. Most
of the reactions were due to non-tuberculous mycobacteria.
& 2005 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserv
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In an earlier publication from this Centre, based on
a 15-year follow-up of a large rural population in
south India, we had demonstrated the presence of
an association between sensitivity to PPD-S at
intake and the incidence of culture-positive tuber-
culosis, which persisted after allowing for the
effect of sex and age.1 While the incidence ined.
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higher than that in the ‘uninfected’ (0–7mm), the
incidence in those with 8–11mm was numerically
higher than in the ‘uninfected’ but not significantly
so; further, it was significantly lower than that in
infected subjects. These findings suggest that the
8–11mm group might be a mixed group, consisting
largely of uninfected subjects. Dual testing with
PPD-B has been reported to be useful for classifying
such subjects as uninfected or infected.2,3 We
present here the findings from our large and unique
data set, employing a multivariate analytical tool.
Two approaches were investigated, one based on
the excess of PPD-S induration over PPD-B indura-
tion, and the other based on a dichotomy of the
absolute value of the PPD-B induration.Materials and methods
A double-blind randomized controlled trial was
initiated in 1968 in about 240,000 subjects in rural
south India to assess the protective efficacy of BCG
vaccination. In this trial, all individuals aged one
year and above were tested with three interna-
tional units of PPD-S and 10 units of PPD-B, derived
from Mycobacterium intracellulare. (PPD-S was
supplied from the Antigen production laboratory,
Atlanta, Georgia, during the first six months of the
intake, and from the BCG department of Statens
Seruminstitut, Copenhagen for the next two years.
PPD-B was from the Antigen production laboratory
in Atlanta, Georgia.) The participants were subse-
quently allocated at random to a placebo, a low
dose of BCG (0.01mg) or a high dose of BCG
(0.1mg). Subjects who had a positive smear/
culture or BCG scar at intake, or were not assessed
for scar status or not ‘vaccinated’ in the trial were
excluded. Of the remaining, only those with a
normal radiograph at intake were considered for
determining the incidence of tuberculosis. The
initial study population was 237,276 (Placebo
79,526, BCG low dose 78,981, BCG high dose
78,769). Since there were no differences in
incidence between the three series,4,5 the total
population of 237,276 was considered for all
further analyses.Investigations
Radiographic examination, followed by sputum
examination of those with an abnormal radiograph,
was undertaken to detect all cases of tuberculosis
over the next 15 years. The detection was throughtotal population survey once in 212 years, selective
follow-up of subjects at higher risk once in 10
months, and passive surveillance through a spe-
cially established clinic in the area. These proce-
dures were for subjects with an induration of
0–15mm to PPD-S at intake. In those with an
induration of 415mm, from 712 years onwards
follow-up was restricted to subjects at especially
high risk (e.g. suspect shadows on radiography) and
a random sample of one-third of the others. Full
details have been reported earlier.4,5Definition of tuberculous infection based
on induration to PPD-S
Considering the distribution of PPD-S results in
68,415 children aged 0–9 years, there was no clear
separation between the presumably uninfected and
the presumably infected subjects, but the dip
between the two distributions was approximately
at 12mm.4 Further, the lower 95% confidence limit
for 556 patients with culture-positive tuberculosis
was 12.6mm.1 Therefore, subjects with an indura-
tion of X12mm were regarded as very likely to
have had a tuberculous infection (‘infected’). The
others were divided in to two groups, i.e. 0–7mm,
comprising subjects who were very unlikely to have
had a tuberculous infection (‘uninfected’), the rest
(8–11mm) being an intermediate group.Definition of non-tuberculous infection
based on induration to PPD-B
Considering the distribution of PPD-B results in the
same 68,415 children, there was no clear division
between non-reactors and reactors, but the lowest
frequency was at 11mm. Further, in 62,290 adults
aged435 years, most of whom are expected to be
reactors, 98% had an induration of 410mm, which
was therefore taken as the cut-off for classifying a
subject as having a non-tuberculous mycobacterial
infection. The same definition had been employed
in our earlier reports also.4,5Assessment of additional value of PPD-B
sensitivity
To explore the additional value of PPD-B sensitivity,
two approaches were employed, each resulting in
six subgroups. In the first, the induration to PPD-S
(0–7, 8–11, 412mm) was considered with the
difference in induration to PPD-S (S) and PPD-B (B)
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initially considered for those with PPD-S induration
of 0–7 and 8–11mm, as suggested by Edwards et
al.,3 namely, difference (S–B) of 2 or less;
difference of 1, 0, 1; difference of 2 or more,
but the first two were combined as they were found
to have very similar risks. In the second approach,
the induration to PPD-S was considered along with a
dichotomous classification of the induration to PPD-
B (10mm or more, 0–9mm).Estimation of incidence
For each period of 212 years, the population at risk
was stratified by sex, age and tuberculin age and
tuberculin sensitivity at intake, and the death rate
and the incidence of tuberculosis were estimated
for each subgroup. Using these in a life table
analysis, the numbers of culture-positive cases
(irrespective of smear) were determined per
100,000 persons in each sub-group. Assuming that
the absentees in every subgroup had similar out-
comes as those investigated, and employing suita-
ble weighting procedures, the incidence (per
100,000) of culture-positive tuberculosis was com-
puted for each of the tuberculin sensitivity groups
set out above. This procedure was employed to
allow for differential losses in the follow-up that
have been described in detail in the earlier
communication.1Statistical methods
Since the period of follow-up was not uniform for
all subjects (planned duration varied from 7.5 to 15
years, and there were interim losses due toTable 1 Incidence of culture-positive tuberculosis, age
various groups based on induration to PPD-S and excess in
Induration to
PPD-S (mm)
Excess of
S over B (S–B)
Number
at risk
Annual
incidence
Perce
by ag
0–14
0–7 Less than 2mm 106728 53 72.7
2mm or more 1794 57 94.0
8–11 Less than 2mm 17245 93 33.2
2mm or more 285 154 60.1
X12 Less than 2mm 71090 301 13.0
2mm or more 40134 355 19.7
Annual incidence of culture-positive tuberculosis (per 100 000
yAdjusted risk of tuberculosis after allowing for age at intake,migration etc.4,5), Cox’s proportional hazard mod-
el6 was employed to assess the statistical signifi-
cance of contrasts between various tuberculin
sensitivity groups, both for the univariate case
and for the multivariate situation when other
prognostic factors such as age at intake, sex and
vaccination status were also taken into account.Results
Role of PPD-B sensitivity in identifying those
with tuberculous infection
The annual incidence of culture-positive tubercu-
losis in those with PPD-S ¼ 0–7mm was unrelated
to the magnitude of the difference in sensitivity
between PPD-S and PPD-B, i.e. 57 and 53 per
100,000 (p ¼ 0:58) in those with difference (S–B) of
X2 and o2mm, respectively (Table 1). In those
with PPD-S ¼ 8–11mm, however, the corresponding
incidences were 154 and 93, respectively, suggest-
ing that the former category (PPD-S reaction larger
than PPD-B reaction by at least 2mm) had a higher
risk (p ¼ 0:28) due probably to a tuberculous
infection; this contrast was more marked in adults
aged 15 years or more, the incidences being 304
and 116, respectively (po0:01). In subjects with a
definitive tuberculous infection (SX12mm), the
corresponding incidences were 355 and 301, re-
spectively (po0:001). Subjects with an PPD-S
excess of 2mm or more were younger than those
with an excess of less than 2mm (Table 1, po0:01).
Also, the proportion of males differed significantly
between the two groups (Table 1, po0:01) in
subjects with 0–7mm (49.2%, 46.3%) and X12mm
(48.0%, 56.6%). As age and sex are both associated
with tuberculosis incidence,1 we undertook aat intake, sex and Adjusted risk of tuberculosis in
duration of PPD-S over PPD-B.
ntage of subjects
e (years) and by sex
Adjusted
RRy
p
15–24 25–44 X45 Male Female
12.4 10.4 4.5 46.3 53.7 1.00
1.7 2.1 2.2 49.2 50.8 1.45 0.34
21.5 28.4 16.9 46.3 53.7 1.00
10.5 10.5 18.9 47.7 52.3 3.23 0.02
18.5 43.0 25.4 56.6 43.4 1.00
18.6 38.9 22.8 48.0 52.0 1.42 o0.001
), smear-positive or smear-negative, over 15 years.
sex and vaccination status.
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(0–7, 8–11, X12mm). This showed that subjects
whose PPD-S induration exceeded PPD-B induration
by at least 2mm consistently had a higher adjusted
relative risk (over 15 years) than those with an
excess of less than 2mm, the contrast being
statistically significant in subjects with 8–11mm
(Adj. RR ¼ 3.2, p ¼ 0:02) and X12mm (Adj. RR
¼ 1.4, po0:001); in subjects with 0–7mm, the
adjusted risk was 1.4 (p ¼ 0:34).
A multivariate analysis on the total data set
yielded two important findings (Table 3, left-hand
side). One is that the adjusted RR for subjects with
S ¼ 8211mm in whom the excess of S over B was
less than 2mm, was 1.04 (p ¼ 0:66), i.e. not
significantly different from that in subjects with
S ¼ 027mm. The other is that subjects with S ¼
8211mm and an excess of at least 2mm had an
adjusted RR of 2.8 that was significantly higher than
that in subjects with S ¼ 027mm (p ¼ 0:04), and
the same as that in subjects with a tuberculous
infection (SX12mm). Similar patterns were evi-
dent with 5- and 10-year follow-up periods.Table 2 Incidence of culture-positive tuberculosis, age
various groups based on indurations to PPD-S and PPD-B.
Induration to
PPD-S (mm)
Induration to
PPD-B (mm)
Number
at risk
Annual
incidence
Percen
by age
0–14
0–7 X10 69,530 63 61.0
0–9 38,992 34 94.5
8–11 X10 17,049 93 32.8
0–9 481 131 62.6
X12 X10 109,919 316 15.2
0–9 1305 323 39.3
Annual incidence of culture-positive tuberculosis (per 100 000
yAdjusted risk of tuberculosis after allowing for age at intake,
Table 3 Adjusted relative risk of tuberculosis (15-year f
Induration
to PPD-S
(mm)
Excess of
PPDS over
PPD-B
(mm)
Number
at risk
Annual
incidence
Adjusted
RRy
P
0–7 — 108,522 52 1.00
8–11 o2 17,245 93 1.04 0.6
X2 285 154 2.79 0.0
X12 — 111,224 332 2.78 o0.0
Annual incidence of culture-positive tuberculosis (per 100,000
yAdjusted risk of tuberculosis after allowing for age at intake,An alternative approach is to sub-divide indivi-
duals with 8–11mm to PPD-S into two groups
according to their PPD-B reactor status (Table 2).
The group with an induration of X10mm to PPD-B,
suggesting the presence of a non-tuberculous
mycobacterial infection (with or without a con-
comitant tuberculous infection), had a culture-
positive incidence of 93 per 100,000, which was
lower than the corresponding incidence of 131 per
100,000 in those with o10mm (p ¼ 0:31). In
subjects with 0–7mm initially to PPD-S, the
difference was in the opposite direction (63 and
34), while in those with X12mm, the difference
was relatively small (316 and 323) and non-
significant.
Subjects with an induration to PPD-B of X10mm
were older than those with an induration of
o10mm (Table 2, po0:001). Also, the proportion
of males differed significantly between the two
PPD-B groups in subjects with PPD-S ¼ 0–7mm
(44.7%, 49.2%) and in those with X12mm (53.6%,
45.9%). Multivariate analysis within each of these
three groups showed that the adjusted relative riskat intake, sex and Adjusted risk of tuberculosis in
tage of subjects
(years) and by sex
Adjusted
RRy
p
15–24 25–44 X45 Male Female
17.7 15.1 6.3 44.7 55.3 1.00
2.5 1.7 1.3 49.2 50.8 1.12 0.36
21.7 28.7 16.9 46.3 53.7 1.00
10.0 9.6 17.9 46.0 54.0 3.23 o0.01
18.6 41.8 24.5 53.6 46.4 1.00
13.7 23.1 23.9 45.9 54.1 1.49 0.03
), smear-positive or smear-negative, over 15 years.
sex and vaccination status.
ollow-up) by PPD-S and PPD-B induration at intake.
Induration
to PPD-B
(mm)
Number
at risk
Annual
incidence
Adjusted
RRy
p
— 108,522 52 1.00
6 X10 17,049 93 1.03 0.73
4 0–9 481 131 2.68 0.02
01 — 111,224 332 2.78 o0.001
), smear-positive or smear-negative, over 15 years.
sex and vaccination status.
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tion of o10mm to PPD-B, the contrast being
statistically significant in subjects with S ¼
8211mm (Adj. RR ¼ 3.2, po0:01) and in those
with SX12mm (Adj. RR ¼ 1.5, p ¼ 0:03); in those
with 0–7mm, the adjusted risk was 1.1 (p ¼ 0:36).
Multivariate analysis of the entire data set
showed that the adjusted RR for S ¼ 8211, BX10
was 1.03, i.e. not significantly different from that
in subjects with S ¼ 027mm (Table 3, right-hand
side). Subjects with S ¼ 8211, Bo10 had a
significantly higher adjusted RR of 2.7 (p ¼ 0:02),
that was very similar to that in subjects with a
tuberculous infection (2.8).
Effect of non-tuberculous mycobacterial
infection on incidence
Subjects with a non-tuberculous mycobacterial
infection (BX10mm) had a lower adjusted relative
risk than those without such an infection. In
subjects with S ¼ 027mm, the adjusted RR was
0.89 (reciprocal of 1.12 in Table 2), which is
suggestive but not statistically significant
(p ¼ 0:36). It was 0.31 (reciprocal of 3.23 in Table
2) for subjects with S ¼ 8211mm (po0:01), and
0.67 (reciprocal of 1.49 in Table 2) for those with
SX12mm (p ¼ 0:03). For the total population, the
adjusted RR (weighted estimate of the three
separate estimates) was approximately 0.69, in-
dicating an overall protective efficacy of 31%.Discussion
The classification of individuals as infected (with
tubercle bacilli) or uninfected has important
clinical and programme implications. For instance,
it could form the basis for BCG vaccination in the
uninfected or chemoprophylaxis to the infected, or
the computation of the annual risk of tuberculous
(ARTI) infection, an important index for the
programme manager. A frequently employed meth-
od is to choose the cut-off point as the dip (anti-
mode) in the distribution of PPD-S induration in
relatively young subjects—for example, children
aged less than 10 years. With this method, definite
non-reactors and definite reactors are identified,
but there is an element of uncertainty about some
due to subjectivity in determining the cut-off
point. In a preliminary report on 624,860 white
navy recruits in the USA, Palmer and Edwards2
concluded that the use of PPD-B in addition to PPD-
S in such situations could significantly improve the
efficiency of classification, as they found strikingdifferences in morbidity between subjects whose
induration to PPD-S exceeded that to PPD-B by at
least 2, 1 to 1, or 2mm or less. The larger study
in 1,124,863 recruits confirmed this conclusion,3
the incidences being 272, 127 and 29 per 100,000,
respectively, with the incidence in the last group
being similar to that in non-reactors (36 per
100,000).
In contrast, Raj Narain and colleagues7 concluded
that dual testing with PPD-B is unlikely to serve a
useful purpose in south India. Their conclusion was
not based on the risk of developing tuberculosis
(such information was not available at the time),
but the finding that the PPD-B reaction was larger
than the PPD-S reaction (which was at least 12mm)
in as many as 25% of 1626 patients with culture-
positive tuberculosis, and 9.4% of 106 children aged
less than 5 years. The corresponding proportions in
our study were 28% in 627 culture-positive patients
and 27% in 1360 children aged less than 5 years.
From Canada, Menzies et al. reported that sensi-
tivity to PPD-B had an important effect on low-
grade reactions (range of 5–9mm) to PPD-T (bio
equivalent of PPD-S), through cross-reactivity, but
negligible effect on reactions of 10+ mm.8
In subjects with an intermediate reaction
(8–11mm) to PPD-S, our findings agree with those
in navy recruits in the USA.2,3 After allowing for the
effect of associated factors such as age and sex, the
incidence in 285 subjects with whose S induration
exceeded B induration by 2mm or more was
significantly higher than that in subjects with a
difference of less than 2mm, and similar to that in
subjects with a tuberculous infection. Similarly,
there were 481 subjects (including all of the 285
above) who were not reactors to PPD-B (0–9mm)
and had an incidence similar to that in infected
subjects. In all, therefore, 481 (2.7%) of the 17,530
subjects could be identified as probably infected,
suggesting that subjects with an intermediate size
reaction to PPD-S (8–11mm) constitute a mixed
group of uninfected and infected subjects, with the
vast majority (97%) not having a tuberculous
infection. Further, even among subjects with a
definite tuberculous infection (PPD-SX12mm), a
large subset could be identified (PPD-BX10mm)
that had a 30% lower risk (p ¼ 0:03). Thus, dual
testing with PPD-B proved to be useful in this
community, but its routine use in real life situations
has to take into account the labour and cost
involved, besides ensuring availability of the PPD-
B antigen, the production of which has been
discontinued in the USA and in Statens Serum-
Institut, Copenhagen. Finally, the utility of this
supplemental test with PPD-B in distinguishing
tuberculosis infection from non-specific reactivity
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closer than what is currently available to a
definitive diagnosis of tuberculosis infection is an
achievable goal.
The focus of the present investigation has been
on the classification of individual subjects as
infected or uninfected for clinical purposes (e.g.
BCG vaccination, chemoprophylaxis). For the epi-
demiologist or programme manager, who would
probably be satisfied with an estimate of the
proportion infected, ‘mixture’ models are an
attractive alternative, especially in situations
where there is a high prevalence of environmental
mycobacteria.9–12 In this approach, the tuberculin
test results are assumed to be a mixture of
three ‘Normal’ distributions, one for reactors
due to a tuberculous infection, one for reactors
due to cross infection with environmental myco-
bacteria, and the third for non-reactors (i.e.
neither infected with tuberculous nor non-tubercu-
lous mycobacteria); the proportions in each cate-
gory, together with the means and standard
deviations of the three Normal distributions, are
then estimated by maximum likelihood analysis.
The ARTI computed from a Mixture model in
Karnataka,9 was almost the same as that obtained
by the conventional method of a critical cut-off,
but in Afghanistan the former was substantially
smaller.10 A study in Korea showed that the
approach is also promising in the context of
changing tuberculin reaction sizes over time,11
while a more theoretical study concluded that the
method is an useful adjuvant when the diagnostic
test lacks in specificity as a result of cross
reactions.12
Palmer and Long cited laboratory studies and
human studies to suggest that infections with
mycobacteria other than BCG create some capacity
to modify the course of subsequent virulent
disease, and concluded that infections with such
organisms constitute a kind of ‘natural’ vaccination
that resembles vaccination with BCG.13 The magni-
tude of protection from non-tuberculous mycobac-
teria (based on univariate analysis) was 60% over a
10-year period in the United Kingdom,14 and 58%
over 3 years in south India.15 Our estimate, based
on multivariate analysis that allows for the effect
of age and sex, is about 30% over a 15-year period.
These findings suggest that infection with PPD-B
prevented progression to tuberculosis disease in
those with an initial tuberculous infection. Evi-
dence of cross protection from natural exposure to
environmental bacteria has also been suggested
from Malawi,16 where the lowest rates of tubercu-
losis were found in subjects with low-grade
sensitivity to PPD-S.17Acknowledgements
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